| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/14/2008 | US20080194570 SOLID PHARMACEUTICAL FORMULATIONS OF A HOMOGENEOUS DISPERSION OF ACTIVE PRINCIPLES HAVING pH-DEPENDENT SOLUBILITY |
| 08/14/2008 | US20080194569 Phthalazinones |
| 08/14/2008 | US20080194563 small molecule protein tyrosine phosphatase inhibitorsuse of said compounds for the treatment of phosphatase-mediated diseases, especially cancer |
| 08/14/2008 | US20080194562 Pyrazole Derivatives For The Inhibition Of Cdk's And Gsk's |
| 08/14/2008 | US20080194561 Compounds |
| 08/14/2008 | US20080194558 Quinazoline analogs as receptor Tyrosine Kinase inhibitors |
| 08/14/2008 | US20080194556 Quinazolines and Their Use as Aurora Kinase Inhibitors |
| 08/14/2008 | US20080194552 Aminopyrimidine Derivatives With Tie2 Inhibiting Activity |
| 08/14/2008 | US20080194546 wherein: one or two of X5, X6 and X8 is N, and the others are CH; R7 is selected from halo, ORO1, SRS1, NRN1RN2, NRN7aC( .dbd. O)RC1, NRN7bSO2RS2a, an optionally substituted C5-20 heteroaryl group, or an optionally substituted C5-20 aryl group, where RO1 and RS1 are selected from H, |
| 08/14/2008 | US20080194537 Tetrapeptide capable of inhibiting binding of the Smac protein to Inhibitors of apoptosis, thus promoting apoptosis or sensitizing cells; antiproliferative and anticarcinogenic agents |
| 08/14/2008 | US20080194534 Retinoic esters with cholesterol; antiproliferative agents; disorders caused by abnormal cellular differentiation; psoriasis, cancers of skin, colon, lungs, breasts, prostate, or ovaries, leukemia, neuroblastomas, eczema, acne; improved wrinkle resistance, skin hydration, sebum secretions |
| 08/14/2008 | US20080194533 Sulfating 17 beta-dihydroequilin or 17 beta-estradiol using tertiary amine-sulfur trioxide complexes and sodium, lithium or potassium salt formation; hormone replacement therapy; hot flashes in postmenopausal women; endometriosis, breast cancer |
| 08/14/2008 | US20080194524 Compounds For the Inhibition of Undesired Cell Proliferation and Use Thereof |
| 08/14/2008 | US20080194514 Methods and Compositions for Inhibiting the Function of Polynucleotide Sequences |
| 08/14/2008 | US20080194512 Compositions and methods for inhibiting viral replication |
| 08/14/2008 | US20080194509 Novel Adenyl Dinucleotides with Antitumour Activity and a Method of preparing Thereof |
| 08/14/2008 | US20080194507 Defibrotide An/Or Oligodeoxyribonucleotides For Treating Angiogenesis-Dependent Tumors |
| 08/14/2008 | US20080194506 Tumors; animal or plant extracts or synthetic DNA; coadministered with a defibrotide, rapamycin, paclitaxel, monocrotaline, BCNU, or cyclophosphamide; angiogenesis inhibitors; breast cancer |
| 08/14/2008 | US20080194490 At4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents |
| 08/14/2008 | US20080194467 Cancer treatment methods using cadherin antagonists in combination with anticancer agents |
| 08/14/2008 | US20080194019 Administering metformin and/or phenformin; for treatment of diabetes and cancer; drug screening |
| 08/14/2008 | US20080193964 Compositions and methods for regulation of calcium-dependent signaling in brain |
| 08/14/2008 | US20080193949 Using selectin concentration as diagnostic indicator of thrombosis |
| 08/14/2008 | US20080193944 Expression vector comprising nucleotide sequences coding cardiac-related ankyrin-repeat protein kinase (CARK) for diagnosis, treatment and prevention of cardiovascular disorders |
| 08/14/2008 | US20080193549 Hoki Fish Liver Oil, Fractions Thereof And Therapeutic Uses |
| 08/14/2008 | US20080193517 Polymer Conjugates of K-252A and Derivatives Thereof |
| 08/14/2008 | US20080193512 Drug Carrier and Drug Carrier Kit for Inhibiting Fibrosis |
| 08/14/2008 | US20080193510 Nucleic acids, peptides, and antibodies for use in diagnosis and therapy; macular degeneration; cancers of the colon, breasts, prostate, liver, pancreas, and mouth; receptor binding assays of the peptide to neovasulatures |
| 08/14/2008 | US20080193509 Liposome Preparation Containing Slightly Water-Soluble Camptothecin |
| 08/14/2008 | US20080193482 Method of cancer screening; method of cancer treatment; and method of auto-immune disease treatment |
| 08/14/2008 | US20080193479 Method and Compositions for the Treatment of Hematologic Cancers |
| 08/14/2008 | US20080193462 Inhibiting tumor cell growth in subject by administering to said subject a combination of a cytotoxic or a chemotherapeutic agent and a composition comprising an insulin-like growth factor receptor-1 (IGF-1R) inhibitor; demonstrating specific approaches to enhance therapeutic window of IGF-1R inhibition |
| 08/14/2008 | US20080193461 Decreasing tumor growth in a subject in need thereof by detecting an increase in expression of Angiopoietin-1 in the tumor or in the bloodstream and providing radiation to the tumor; includes diagnostic methods for detecting normalization window in tumor vasculature |
| 08/14/2008 | US20080193453 Anti Tfr Antibody |
| 08/14/2008 | US20080193448 Combinations and Methods of Using an Indolinone Compound |
| 08/14/2008 | US20080193445 Novel anti-IGF-IR antibodies and uses thereof |
| 08/14/2008 | US20080193438 Using bioassay comprising phosphatase and tensin homolog (PTEN) elongation factor-2 kinase to identify modulators of phosphatase and tensin homolog (PTEN) activites; treating cell proliferative disorders; antitumor agents |
| 08/14/2008 | US20080193433 Water free of pathogens, pyrogens, heavy metals, and viruses, sprouted grain comprising digestive enzymes and undenatured whey protein; glutathione, triozyme; cancer, hepatitis and human immunodeficiency virus |
| 08/14/2008 | US20080193419 Cancer Treatment Using Viruses, Fluoropyrimidines and Camptothecins |
| 08/14/2008 | US20080193415 HSA-free formulations of interferon-beta |
| 08/14/2008 | US20080193414 Use of an Immunoglobulin Domain-Containing Cell Surface Recognition Molecule For Treating Diseases |
| 08/14/2008 | US20080193410 Treating warts or verrucae that are induced by papillomavirus; killed mumps virus, candida or trichophyton extract; cytokines or colony stimulating factor |
| 08/14/2008 | US20080193408 Treatment of resistant or refractory cancers with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
| 08/14/2008 | US20080193381 Heterodimers of glutamic acid |
| 08/14/2008 | US20080193375 Lung cancer-targeted peptides and applications thereof |
| 08/14/2008 | CA2677799A1 Gnaq mutations in melanoma |
| 08/14/2008 | CA2677661A1 Tricyclic compounds |
| 08/14/2008 | CA2677481A1 Triazole compounds that modulate hsp90 activity |
| 08/14/2008 | CA2677365A1 2-amino-5, 7-dihydro-6h-pyrrolo [3, 4-d] pyrimidine derivatives as hsp- 90 inhibitors for treating cancer |
| 08/14/2008 | CA2677336A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, the use thereof and processes for the preparation thereof |
| 08/14/2008 | CA2676422A1 Oxabicycloheptane and oxabicycloheptene phosphatase inhibitors, their preparation and use |
| 08/14/2008 | CA2675558A1 Pi 3-kinase inhibitors and methods of their use |
| 08/13/2008 | EP1956374A1 Detection and treatment of cancer |
| 08/13/2008 | EP1956081A1 Method for detection of human precursor t cell and precursor b cell |
| 08/13/2008 | EP1956079A1 Neural progenitor cells |
| 08/13/2008 | EP1956078A2 Liver engrafting cells, assays, and uses thereof |
| 08/13/2008 | EP1956030A1 Secreted and transmembrane polypeptides and nucleic acids endoding the same |
| 08/13/2008 | EP1956020A2 1-[2-(heterocyclyl-aminomethyl)-piperidin-1-YL]-1-(2-methyl-5-phenyl-heterocyclyl)-methanone derivatives and related compounds as orexin-1 antagonists for the treatment of obesity |
| 08/13/2008 | EP1956017A1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and method of reducing TNF alpha levels |
| 08/13/2008 | EP1956013A1 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |
| 08/13/2008 | EP1956010A1 Bicyclical heterocycles, medicines containing these compounds, their application and method for their production |
| 08/13/2008 | EP1955714A1 Detection and treatment of cancer |
| 08/13/2008 | EP1955709A2 Adjuvant compositions for enhancing immune responses to polynucleotide-based vaccines |
| 08/13/2008 | EP1955708A1 Novel memory ctl induction potentiator |
| 08/13/2008 | EP1955703A1 Viruses for the treatment of cellular proliferative disorders |
| 08/13/2008 | EP1955696A2 Use of EDG receptor binding agents in cancer |
| 08/13/2008 | EP1954720A1 Antibodies and immunotoxins that target human glycoprotein nmb |
| 08/13/2008 | EP1954699A1 PYRIDO-,PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS |
| 08/13/2008 | EP1954698A1 Spirocyclic compounds as hdac inhibitors |
| 08/13/2008 | EP1954690A1 Benzamide compounds useful as histone deacetylase inhibitors |
| 08/13/2008 | EP1954681A2 Compounds and methods for thiol-containing compound efflux and cancer treatment |
| 08/13/2008 | EP1954317A2 Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use |
| 08/13/2008 | EP1954284A1 Method of treating cancers with saha and pemetrexed |
| 08/13/2008 | EP1954281A2 Cancer treatment method |
| 08/13/2008 | EP1954278A2 Combination comprising a pyrimidylaminobenzamides and a flt-3 inhibitor for treating proliferative diseases |
| 08/13/2008 | EP1954274A2 Substituted quinolones and methods of use |
| 08/13/2008 | EP1954272A2 Treatment of cancer with sorafenib |
| 08/13/2008 | EP1954269A2 Neuroendocrine tumor treatment using mtor inhibitors |
| 08/13/2008 | EP1954263A2 Composition for increasing steady state plasma levels of bicalutamide |
| 08/13/2008 | EP1954255A1 A combination comprising squalene, a phospholipid and an omega 3 fatty acid for the treatment of cancer |
| 08/13/2008 | EP1954254A2 Modulating endoplasmic reticulum stress in the treatment of tuberous sclerosis |
| 08/13/2008 | EP1954245A2 Compositions of lipoxygenase inhibitors |
| 08/13/2008 | EP1869032B1 Pyrimidine derivatives for use as anticancer agents |
| 08/13/2008 | EP1753723B1 Substituted quinoline derivatives as mitotic kinesin inhibitors |
| 08/13/2008 | EP1704136B1 Gossypol derivatives, production method thereof and uses of same |
| 08/13/2008 | EP1664070B1 Methods for inhibiting tumor cell proliferation involving platinum complexes |
| 08/13/2008 | EP1585749B1 Diazepinoindole derivatives as kinase inhibitors |
| 08/13/2008 | EP1581471B9 Cyclopentenone derivatives for cancer therapy |
| 08/13/2008 | EP1505992B1 Method for reducing pain using oncolytic viruses |
| 08/13/2008 | EP1501803B1 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 08/13/2008 | EP1501566B1 Medical products comprising a haemocompatible coating, production and use thereof |
| 08/13/2008 | EP1496905B1 Modulators of hedgehog signaling pathways, compositions and uses related thereto |
| 08/13/2008 | EP1495030B1 Non-steroidal progesterone receptor modulators |
| 08/13/2008 | EP1483290B1 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 08/13/2008 | EP1476200A4 Compositions and method for regulation of calcium-dependent signalling in brain |
| 08/13/2008 | EP1467979B1 Fused heterocyclic compounds and analogs thereof modulators of nuclear hormone receptor function |
| 08/13/2008 | EP1436279B1 Chemical compounds |
| 08/13/2008 | EP1386923B1 Novel adenine derivatives |
| 08/13/2008 | EP1289916B1 Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls |
| 08/13/2008 | EP1272636B1 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |